NEORX CORPORATION KEY EXECUTIVE SEVERANCE AGREEMENTNeorx Corporation Key Executive Severance Agreement • October 19th, 2004 • Neorx Corp • In vitro & in vivo diagnostic substances
Contract Type FiledOctober 19th, 2004 Company IndustryThis Key Executive Severance Agreement (VP) (this “Agreement”), dated as of October 25, 2004, is entered into by and between NEORX CORPORATION, a Washington corporation (as supplemented by Section 10, the “Company”), and Susan D. Berland (the “Executive”).